White Announces Re-election of Audit Committee Members upon Term Expiration
Key facts
- White Announces Re-election of Audit Committee Members upon Term Expiration
- White has restructured its Audit Committee effective June 9, 2026, following the expiration of the previous term. Incumbent independent directors were re-elected, and Mr. Cheng Chien-hsin has been newly appointed.
- Source: PR Times
- Date: June 9, 2026
Direct answer
White has restructured its Audit Committee effective June 9, 2026, following the expiration of the previous term. Incumbent independent directors were re-elected, and Mr. Cheng Chien-hsin has been newly appointed.
- Citation
- White Announces Re-election of Audit Committee Members upon Term Expiration (June 9, 2026), PR Times
- Source
- PR Times
- Date
- June 9, 2026
White has restructured its Audit Committee effective June 9, 2026, following the expiration of the previous term. Incumbent independent directors were re-elected, and Mr. Cheng Chien-hsin has been newly appointed.
📋 Article Processing Timeline
- 📰 Published: June 9, 2026 at 09:00
- 🔍 Collected: June 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 13, 2026 at 05:13 (69h 13m after Collected)
1. Date of Change: 2026/06/09
2. Name of Functional Committee: Audit Committee
3. Former Members:
(1) Independent Director: Lin Shui-long
(2) Independent Director: Lai Shan-kuei
(3) Independent Director: Wu Yung-chang
4. Resumes of Former Members:
(1) Independent Director: Lin Shui-long, Independent Director of the Company
(2) Independent Director: Lai Shan-kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-chang, Independent Director of the Company
5. New Members:
(1) Independent Director: Lin Shui-long
(2) Independent Director: Lai Shan-kuei
(3) Independent Director: Wu Yung-chang
(4) Independent Director: Cheng Chien-hsin
6. Resumes of New Members:
(1) Independent Director: Lin Shui-long, Independent Director of the Company
(2) Independent Director: Lai Shan-kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-chang, Independent Director of the Company
(4) Independent Director: Cheng Chien-hsin, Director and General Manager of San Fu Biomedical Co., Ltd.
7. Nature of Change (please enter 'resignation', 'removal', 'end of term', 'death', or 'new appointment'):
End of Term
8. Reason for Change: The Company held its annual general meeting on June 9, 2026, where all directors were re-elected, leading to the formation of a new Audit Committee by the newly appointed independent directors.
9. Previous Term (e.g., 2023/05/24 ~ 2026/05/23): 2023/05/24 ~ 2026/05/23
10. Effective Date of New Appointment: 2026/06/09
11. Other Matters to be Disclosed: None.
2. Name of Functional Committee: Audit Committee
3. Former Members:
(1) Independent Director: Lin Shui-long
(2) Independent Director: Lai Shan-kuei
(3) Independent Director: Wu Yung-chang
4. Resumes of Former Members:
(1) Independent Director: Lin Shui-long, Independent Director of the Company
(2) Independent Director: Lai Shan-kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-chang, Independent Director of the Company
5. New Members:
(1) Independent Director: Lin Shui-long
(2) Independent Director: Lai Shan-kuei
(3) Independent Director: Wu Yung-chang
(4) Independent Director: Cheng Chien-hsin
6. Resumes of New Members:
(1) Independent Director: Lin Shui-long, Independent Director of the Company
(2) Independent Director: Lai Shan-kuei, Independent Director of the Company
(3) Independent Director: Wu Yung-chang, Independent Director of the Company
(4) Independent Director: Cheng Chien-hsin, Director and General Manager of San Fu Biomedical Co., Ltd.
7. Nature of Change (please enter 'resignation', 'removal', 'end of term', 'death', or 'new appointment'):
End of Term
8. Reason for Change: The Company held its annual general meeting on June 9, 2026, where all directors were re-elected, leading to the formation of a new Audit Committee by the newly appointed independent directors.
9. Previous Term (e.g., 2023/05/24 ~ 2026/05/23): 2023/05/24 ~ 2026/05/23
10. Effective Date of New Appointment: 2026/06/09
11. Other Matters to be Disclosed: None.
FAQ
What is the role of White's Audit Committee?
It oversees financial reporting and internal controls, composed entirely of independent directors for objective governance.
What is Mr. Cheng Chien-hsin's professional background?
He is Director and General Manager of San Fu Biomedical, with extensive biotech management experience.
How does this change impact the company?
This routine renewal enhances governance stability and adds industry-specific expertise to the board.